Analysis and Perspectives

Aug 19, 2022

Currently, more than 70 companies are evaluating 235+ AAV vectors in gene therapy at different stages to improve the therapeutics segment.

Aug 17, 2022

Interoperability solutions in healthcare are improving the patient experience by streamlining care delivery. Major companies in the market

Aug 12, 2022

The expected launch of newly approved Molluscum Contagiosum therapies such as VP-102 and SB206 are expected to drive the therapeutics segment in the coming years.

Aug 10, 2022

Globally, Telepsychiatry demand is rising at an immense pace. Key companies are working in the market to fulfill their needs. Due to various benefits, the market is

Aug 08, 2022

The Dystrophic Epidermolysis Bullosa treatment market has a promising outlook. Various gene therapies in different stages are in the pipeline.

Aug 05, 2022

Currently, the PML Therapeutics pipeline mainly comprises early phase assets. Limited companies are investigating in PML treatment options.

Aug 03, 2022

The role of Artificial Intelligence in Mental Health is growing at an immense pace. The application of AI is providing immense benefit to user

Aug 01, 2022

Several late-stage therapies developed by leading players for generalized myasthenia gravis treatment are expected to enter the therapeutics market

Jul 29, 2022

Currently, there is no effective curative ADPKD treatment. However, leading companies in the therapeutics segment are evaluating novel drugs.

Jul 25, 2022

Bronchopulmonary Dysplasia Treatment Market is expected to showcase massive growth as several pharma companies are developing therapies